Deutsche Bank’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $547K | Sell |
67,558
-9,927
| -13% | -$71K | ﹤0.01% | 2584 |
|
|
2026
Q2 | $506K | Buy |
+77,485
| New | +$369K | ﹤0.01% | 2767 |
|
|
2025
Q2 | – | Sell |
-17,102
| Closed | -$45.7K | – | 3602 |
|
|
2025
Q1 | $45.7K | Sell |
17,102
-5,363
| -24% | -$16.7K | ﹤0.01% | 3390 |
|
|
2024
Q4 | $79.1K | Sell |
22,465
-400
| -2% | -$1.81K | ﹤0.01% | 3351 |
|
|
2024
Q3 | $108K | Hold |
22,865
| – | – | ﹤0.01% | 3193 |
|
|
2024
Q2 | $107K | Buy |
+22,865
| New | +$110K | ﹤0.01% | 3086 |
|
|
2020
Q1 | – | Sell |
-1,338
| Closed | -$14K | – | 4289 |
|
|
2019
Q4 | $14K | Buy |
+1,338
| New | +$28.7K | ﹤0.01% | 4395 |
|
|
2019
Q3 | – | Sell |
-512
| Closed | -$19K | – | 4841 |
|
|
2019
Q2 | $19K | Buy |
512
+502
| +5,020% | +$35.5K | ﹤0.01% | 4820 |
|
|
2019
Q1 | $0 | Buy |
+10
| New | +$404 | ﹤0.01% | 5142 |
|
|
2018
Q4 | – | Sell |
-10
| Closed | – | – | 5132 |
|
|
2018
Q3 | $0 | Sell |
10
-15
| -60% | -$949 | ﹤0.01% | 5331 |
|
|
2018
Q2 | $2K | Buy |
+25
| New | +$5.1K | ﹤0.01% | 5304 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 5360 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4973 |
|
|
2017
Q3 | – | Sell |
-1
| Closed | -$718 | – | 4851 |
|
|
2017
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4905 |
|
|
2017
Q1 | $0 | Buy |
+1
| New | +$1.21K | ﹤0.01% | 4873 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4881 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4883 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 5151 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 5120 |
|
|
2015
Q4 | – | Sell |
-16
| Closed | -$67.6K | – | 5245 |
|
|
2015
Q3 | $78K | Sell |
16
-36
| -69% | -$217K | ﹤0.01% | 4210 |
|
|
2015
Q2 | $266K | Buy |
52
+51
| +5,100% | +$253K | ﹤0.01% | 3744 |
|
|
2015
Q1 | $4K | Sell |
1
-17
| -94% | -$83.5K | ﹤0.01% | 4918 |
|
|
2014
Q4 | $88K | Buy |
+18
| New | +$88K | ﹤0.01% | 4802 |
|
|
2014
Q3 | – | Sell |
-84
| Closed | -$583K | – | 5861 |
|
|
2014
Q2 | $688K | Buy |
84
+78
| +1,300% | +$958K | ﹤0.01% | 3243 |
|
|
2014
Q1 | $147K | Buy |
6
+5
| +500% | +$123K | ﹤0.01% | 4057 |
|
|
2013
Q4 | $23K | Sell |
1
-10
| -91% | -$175K | ﹤0.01% | 4684 |
|
|
2013
Q3 | $220K | Buy |
11
+5
| +83% | +$104K | ﹤0.01% | 4061 |
|
|
2013
Q2 | $133K | Buy |
+6
| New | +$134K | ﹤0.01% | 4059 |
|
Other funds holding ACHV
Deutsche Bank's ACHV Position: Q3 2026 in Review
Deutsche Bank reduced its Achieve Life Sciences (ACHV) stake by 13% in Q3 2026, selling an estimated $71K and leaving 67,558 shares worth $547K. The position accounts for ﹤0.01% of the portfolio, ranked #2584.
Deutsche Bank first reported a position in ACHV in Q2 2013 and has held it in 22 quarters since. The position peaked at $688K in Q2 2014. 35 funds tracked by Wall St. Rank hold ACHV as of Q3 2026.
- Deutsche Bank held 67,558 shares of Achieve Life Sciences worth $547K as of Q3 2026.
- Deutsche Bank sold 9,927 Achieve Life Sciences shares in Q3 2026, an estimated $71K.
- Achieve Life Sciences made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2584 holding.
- Deutsche Bank first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 22 quarters since.
- Deutsche Bank's Achieve Life Sciences position peaked at $688K in Q2 2014.
- 35 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.